PMID- 37697944 OWN - NLM STAT- MEDLINE DCOM- 20231220 LR - 20240314 IS - 2573-8348 (Electronic) IS - 2573-8348 (Linking) VI - 6 IP - 12 DP - 2023 Dec TI - The influence of partial gastrectomy for gastric cancer on the spontaneous disappearance of Helicobacter pylori: A single-center prospective study. PG - e1903 LID - 10.1002/cnr2.1903 [doi] LID - e1903 AB - BACKGROUND/AIMS: Helicobacter pylori (HP) eradication is recommended after endoscopic treatment of early gastric cancer (EGC). Cases of spontaneous HP resolution after partial gastrectomy due to environmental changes have been reported; however, there is no evidence for the efficacy of HP eradication in suppressing carcinogenesis and also no reports on the natural history of HP after partial gastrectomy in gastric cancer (GC). To report the natural history of HP in patients with GC and HP infection after partial gastrectomy. METHODS AND RESULTS: We prospectively studied the rate of spontaneous disappearance of HP after partial gastrectomy in patients with GC. From April 2016 to May 2020, 80 patients underwent partial gastrectomy, including 9 cases of proximal gastrectomy (PG), and 71 cases of distal gastrectomy (DG). The presence of HP was confirmed in the stool antigen test 1 year after operation, HP infection persisted in 46 patients (57.5%) and disappeared in 34 patients (42.5%). In univariate analysis, only proton pump inhibitor (PPI) use was a significant contributing factor for the spontaneous resolution of HP infection, especially in the DG group. However, there was no difference in the rates of HP disappearance between Billroth-I and Roux-en-Y reconstructions in the DG group. CONCLUSION: The HP spontaneously disappeared in 42.5% of the GC patients within 1 year after partial gastrectomy. Further investigation in a larger cohort is needed to elucidate the underlying mechanisms. CI - (c) 2023 The Authors. Cancer Reports published by Wiley Periodicals LLC. FAU - Yanagawa, Senichiro AU - Yanagawa S AUID- ORCID: 0000-0002-3076-8622 AD - Department of Surgery, Onomichi General Hospital, Hiroshima, Japan. FAU - Fujikuni, Nobuaki AU - Fujikuni N AUID- ORCID: 0009-0009-8702-6601 AD - Department of Surgery, Onomichi General Hospital, Hiroshima, Japan. AD - Department of Digestive Surgery, Hiroshima Prefectural Hospital, Hiroshima, Japan. FAU - Tanabe, Kazuaki AU - Tanabe K AUID- ORCID: 0000-0002-8650-2735 AD - Department of Perioperative and Critical Care Management, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. FAU - Nakahara, Masahiro AU - Nakahara M AUID- ORCID: 0009-0007-5564-0610 AD - Department of Surgery, Onomichi General Hospital, Hiroshima, Japan. FAU - Noriyuki, Toshio AU - Noriyuki T AUID- ORCID: 0000-0002-0037-0496 AD - Department of Surgery, Onomichi General Hospital, Hiroshima, Japan. LA - eng PT - Journal Article DEP - 20230912 PL - United States TA - Cancer Rep (Hoboken) JT - Cancer reports (Hoboken, N.J.) JID - 101747728 SB - IM MH - Humans MH - Prospective Studies MH - *Helicobacter pylori MH - *Stomach Neoplasms/surgery MH - Gastrectomy/adverse effects MH - *Helicobacter Infections/complications/diagnosis/epidemiology PMC - PMC10728519 OTO - NOTNLM OT - Helicobacter pylori OT - gastric cancer OT - partial gastrectomy OT - spontaneous disappearance COIS- The authors have stated explicitly that there are no conflicts of interest in connection with this article. EDAT- 2023/09/12 06:41 MHDA- 2023/12/20 06:42 PMCR- 2023/09/12 CRDT- 2023/09/12 04:13 PHST- 2023/08/02 00:00 [revised] PHST- 2023/04/23 00:00 [received] PHST- 2023/08/27 00:00 [accepted] PHST- 2023/12/20 06:42 [medline] PHST- 2023/09/12 06:41 [pubmed] PHST- 2023/09/12 04:13 [entrez] PHST- 2023/09/12 00:00 [pmc-release] AID - CNR21903 [pii] AID - 10.1002/cnr2.1903 [doi] PST - ppublish SO - Cancer Rep (Hoboken). 2023 Dec;6(12):e1903. doi: 10.1002/cnr2.1903. Epub 2023 Sep 12.